Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2015 (2015), Article ID 108139, 9 pages
http://dx.doi.org/10.1155/2015/108139
Research Article

Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study

1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
2Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02114, USA
3Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
4Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA

Received 22 April 2015; Revised 28 June 2015; Accepted 6 July 2015

Academic Editor: Suresh C. Tiwari

Copyright © 2015 Andrew S. Allegretti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Ginès and R. W. Schrier, “Renal failure in cirrhosis,” The New England Journal of Medicine, vol. 361, no. 13, pp. 1279–1290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Ginès, M. Guevara, V. Arroyo, and J. Rodés, “Hepatorenal syndrome,” The Lancet, vol. 362, no. 9398, pp. 1819–1827, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Garcia-Tsao, C. R. Parikh, and A. Viola, “Acute kidney injury in cirrhosis,” Hepatology, vol. 48, no. 6, pp. 2064–2077, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. M. Wadei, M. L. Mai, N. Ahsan, and T. A. Gonwa, “Hepatorenal syndrome: pathophysiology and management,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 5, pp. 1066–1079, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. du Cheyron, B. Bouchet, J.-J. Parienti, M. Ramakers, and P. Charbonneau, “The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis,” Intensive Care Medicine, vol. 31, no. 12, pp. 1693–1699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Cholongitas, M. Senzolo, D. Patch, S. Shaw, J. O'Beirne, and A. K. Burroughs, “Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 7, pp. 744–750, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. D. Tsien, R. Rabie, and F. Wong, “Acute kidney injury in decompensated cirrhosis,” Gut, vol. 62, no. 1, pp. 131–137, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Wiesner, E. Edwards, R. Freeman et al., “Model for end-stage liver disease (MELD) and allocation of donor livers,” Gastroenterology, vol. 124, no. 1, pp. 91–96, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Moreau, R. Jalan, P. Gines et al., “Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis,” Gastroenterology, vol. 144, no. 7, pp. 1426.e9–1437.e9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Lee, J.-H. Lee, S. Oh et al., “CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis,” Liver International, vol. 35, no. 1, pp. 46–57, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Ginès, A. Escorsell, P. Ginès et al., “Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites,” Gastroenterology, vol. 105, no. 1, pp. 229–236, 1993. View at Google Scholar · View at Scopus
  12. C. Alessandria, O. Ozdogan, M. Guevara et al., “MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation,” Hepatology, vol. 41, no. 6, pp. 1282–1289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Martin-Llahi, M. Guevara, A. Torre et al., “Prognostic importance of the cause of renal failure in patients with cirrhosis,” Gastroenterology, vol. 140, no. 2, pp. 488.e4–496.e4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Salerno, A. Gerbes, P. Ginès, F. Wong, and V. Arroyo, “Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis,” Gut, vol. 56, no. 9, pp. 1310–1318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Arroyo, P. Ginès, A. L. Gerbes et al., “Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis,” Hepatology, vol. 23, no. 1, pp. 164–176, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Francoz, D. Prié, W. AbdelRazek et al., “Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score,” Liver Transplantation, vol. 16, no. 10, pp. 1169–1177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Wong, M. K. Nadim, J. A. Kellum et al., “Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis,” Gut, vol. 60, no. 5, pp. 702–709, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Wong, J. G. O'Leary, K. R. Reddy et al., “New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection,” Gastroenterology, vol. 145, no. 6, pp. 1280.e1–1288.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Belcher, G. Garcia-Tsao, A. J. Sanyal et al., “Association of AKI With mortality and complications in hospitalized patients with cirrhosis,” Hepatology, vol. 57, no. 2, pp. 753–762, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. de Araujo and M. R. Alvares-da-Silva, “Akin criteria as a predictor of mortality in cirrhotic patients after spontaneous bacterial peritonitis,” Annals of Hepatology, vol. 13, no. 3, pp. 390–395, 2014. View at Google Scholar · View at Scopus
  21. “Section 2: AKI definition,” Kidney International Supplements, vol. 2, no. 1, pp. 19–36, 2011.
  22. J. Altamirano, C. Fagundes, M. Dominguez et al., “Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis,” Clinical Gastroenterology and Hepatology, vol. 10, no. 1, pp. 65.e3–71.e3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Fagundes, R. Barreto, M. Guevara et al., “A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis,” Journal of Hepatology, vol. 59, no. 3, pp. 474–481, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. P. A. Harris, R. Taylor, R. Thielke, J. Payne, N. Gonzalez, and J. G. Conde, “Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support,” Journal of Biomedical Informatics, vol. 42, no. 2, pp. 377–381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Sort, M. Navasa, V. Arroyo et al., “Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis,” The New England Journal of Medicine, vol. 341, no. 6, pp. 403–409, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. K.-H. Tu, C.-C. Jenq, M.-H. Tsai et al., “Outcome scoring systems for short-term prognosis in critically ill cirrhotic patients,” Shock, vol. 36, no. 5, pp. 445–450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. H.-C. Pan, C.-C. Jenq, M.-H. Tsai et al., “Risk models and scoring systems for predicting the prognosis in critically ill cirrhotic patients with acute kidney injury: a prospective validation study,” PLoS ONE, vol. 7, no. 12, Article ID e51094, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Follo, J. M. Llovet, M. Navasa et al., “Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis,” Hepatology, vol. 20, no. 6, pp. 1495–1501, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. J. G. Abuelo, “Normotensive ischemic acute renal failure,” The New England Journal of Medicine, vol. 357, no. 8, pp. 797–805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Barreto, C. Fagundes, M. Guevara et al., “Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival,” Hepatology, vol. 59, no. 4, pp. 1505–1513, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Perazella, S. G. Coca, M. Kanbay, U. C. Brewster, and C. R. Parikh, “Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 6, pp. 1615–1619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. G. H. Betjes and I. Bajema, “The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited,” Journal of Nephrology, vol. 19, no. 2, pp. 229–233, 2006. View at Google Scholar · View at Scopus
  33. C. M. van Slambrouck, F. Salem, S. M. Meehan, and A. Chang, “Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction,” Kidney International, vol. 84, no. 1, pp. 192–197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Rössle and A. L. Gerbes, “TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update,” Gut, vol. 59, no. 7, pp. 988–1000, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. L. L. Gluud, K. Christensen, E. Christensen, and A. Krag, “Terlipressin for hepatorenal syndrome,” Cochrane Database of Systematic Reviews, vol. 9, Article ID CD005162, 2012. View at Google Scholar · View at Scopus
  36. M. Martín-Llahí, M.-N. Pépin, M. Guevara et al., “Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study,” Gastroenterology, vol. 134, no. 5, pp. 1352–1359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. C. Q. Velez and P. J. Nietert, “Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials,” The American Journal of Kidney Diseases, vol. 58, no. 6, pp. 928–938, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Ghosh, N. S. Choudhary, A. K. Sharma et al., “Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study,” Liver International, vol. 33, no. 8, pp. 1187–1193, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Esrailian, E. R. Pantangco, N. L. Kyulo, K.-Q. Hu, and B. A. Runyon, “Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome,” Digestive Diseases and Sciences, vol. 52, no. 3, pp. 742–748, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. E. T. Schroeder, G. H. Anderson Jr., and H. Smulyan, “Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome,” Kidney International, vol. 15, no. 1, pp. 54–61, 1979. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Castells, J. Saló, R. Planas et al., “Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study,” Hepatology, vol. 20, no. 3, pp. 584–591, 1994. View at Publisher · View at Google Scholar · View at Scopus